-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Production Process of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one in the Chemical Industry
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one, also known as Olanzapine, is an antipsychotic medication used to treat schizophrenia and other mental health conditions.
The compound was first synthesized in 1962 by Lafon Laboratories, and since then, it has become one of the most widely used antipsychotic medications worldwide.
The production process of Olanzapine involves several steps, including the synthesis of the basic structure, the introduction of the desired functional groups, and the final refinement of the molecule.
The following is a detailed overview of the production process of Olanzapine.
Step 1: Synthesis of the Basic Structure
The production of Olanzapine begins with the synthesis of the basic structure of the compound.
This involves the reaction of chlorobenzene with propene to produce 2-chlorobenzene, which is then treated with sodium hydroxide to form a salts.
The resulting product is then reduced with hydrogen in the presence of a catalyst such as palladium on barium sulfate to produce 2-bromobenzene.
Step 2: Introduction of the Desired Functional Groups
The next step in the production process of Olanzapine is the introduction of the desired functional groups.
This involves the reaction of 2-bromobenzene with α-fluoroacetophenone and 8-bromo-7,8-dihydro-1H-azepino[5,4-d][1,4]benzoxazepine in the presence of a Lewis acid catalyst such as aluminum chloride.
This reaction Results in the formation of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one, which is the active ingredient in Olanzapine.
Step 3: Final Refinement of the Molecule
The final step in the production process of Olanzapine is the final refinement of the molecule.
This involves the purification of the 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one to remove any impurities and ensure that the final product meets the required purity standards.
This can be achieved through various methods such as crystallization, chromatography, and filtration.
Challenges in the Production of Olanzapine
The production of Olanzapine can be challenging due to the complexity of the synthesis process and the need for strict control over the reaction conditions.
The process also requires the use of specialized equipment and the handling of hazardous chemicals, making it essential to follow safety protocols and guidelines.
In addition, the purification process can be time-consuming and costly, requiring the use of advanced techniques and equipment.
Advances in the Production of Olanzapine
In recent years, there have been advances in the production process of Olanzapine, including the development of new synthesis methods and the use of advanced technologies such as continuous flow manufacturing and microsolvation.
These advances have led to increased efficiency, reduced costs, and improved quality control in the production of Olanzapine.
Conclusion
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3